FEM1C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.636200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.768200E-01
Normal-vs-Stage2
7.249400E-01
Normal-vs-Stage3
4.334200E-01
Normal-vs-Stage4
1.967760E-01
Stage1-vs-Stage2
9.928800E-01
Stage1-vs-Stage3
1.431170E-01
Stage1-vs-Stage4
1.382770E-01
Stage2-vs-Stage3
2.530600E-01
Stage2-vs-Stage4
1.075800E-01
Stage3-vs-Stage4
6.944300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.759000E-01
Normal-vs-AfricanAmerican
7.578200E-01
Normal-vs-Asian
8.527200E-01
Caucasian-vs-AfricanAmerican
8.436200E-01
Caucasian-vs-Asian
9.232600E-01
AfricanAmerican-vs-Asian
8.553200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.196600E-01
Normal-vs-Female
8.346400E-01
Male-vs-Female
3.656600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.007400E-01
Normal-vs-Age(41-60Yrs)
4.182600E-01
Normal-vs-Age(61-80Yrs)
9.011000E-01
Normal-vs-Age(81-100Yrs)
6.475000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.921800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.207800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.770600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.081600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.723900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.569600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.740400E-01
Normal-vs-Daily Drinker
7.990800E-01
Normal-vs-Weekly Drinker
8.172400E-01
Normal-vs-Occasional Drinker
6.214600E-01
Normal-vs-Social Drinker
9.656000E-01
Non Drinker-vs-Daily Drinker
2.702200E-01
Non Drinker-vs-Weekly Drinker
9.209600E-01
Non Drinker-vs-Occasional Drinker
7.921600E-01
Non Drinker-vs-Social Drinker
4.263000E-01
Daily Drinker-vs-Weekly Drinker
3.861200E-01
Daily Drinker-vs-Occasional Drinker
1.506620E-01
Daily Drinker-vs-Social Drinker
6.617800E-01
Weekly Drinker-vs-Occasional Drinker
7.394400E-01
Weekly Drinker-vs-Social Drinker
6.114600E-01
Occasional Drinker-vs-Social Drinker
2.979400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.842840E-01
Normal-vs-Grade 2
5.305800E-02
Normal-vs-Grade 3
6.146300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.443400E-03
Grade 1-vs-Grade 3
9.862000E-02
Grade 1-vs-Grade 4
1.842840E-01
Grade 2-vs-Grade 3
1.786170E-01
Grade 2-vs-Grade 4
5.305800E-02
Grade 3-vs-Grade 4
6.146300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.838400E-01
Normal-vs-NonDiabetic
7.906400E-01
Diabetic-vs-NonDiabetic
7.662400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.473400E-01
Normal-vs-NoPancreatitis
8.257200E-01
Pancreatitis-vs-NoPancreatitis
8.396200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.372200E-01
Normal-vs-N1
6.918800E-01
N0-vs-N1
2.388200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.439200E-01
Normal-vs-TP53-NonMutant
8.160600E-01
TP53-Mutant-vs-TP53-NonMutant
1.724790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
